Data cannot be made available due to privacy concerns around sensitive information (criminal records) pertaining to young people at this time. The conditions of the existing ethics agreement does not permit for data sharing. To access the data, interested parties will need to seek permission from the Victorian Department of Justice and Community Safety (Youth Justice) Human Research Ethics Committee (<ethics@justice.vic.gov.au>).

Introduction {#sec001}
============

Crystalline methamphetamine (CM; also known as 'crystal meth' or 'ice') is a stimulant commonly smoked or injected as a recreational drug \[[@pone.0229389.ref001],[@pone.0229389.ref002]\]. As with other forms of methamphetamine use, CM use normally results in feelings of euphoria and reduced inhibitions\[[@pone.0229389.ref002]\]. However, it is more potent, addictive, and faster acting than other forms of methamphetamine\[[@pone.0229389.ref001]\]. Moreover, CM is increasingly the main form of methamphetamine used in Australia \[[@pone.0229389.ref003]\]. Adverse psychological effects of CM use include anxiety, aggression, paranoia, irritability, depression, violence, and psychotic symptoms\[[@pone.0229389.ref004]--[@pone.0229389.ref009]\].

Few large-scale prevalence studies have been undertaken to assess the prevalence of CM use in the general community. The 2016 Australian National Drug Strategy Household Survey reported that the highest proportion of people using CM were in the adolescent and young adult age categories \[[@pone.0229389.ref003]\]. Among Australians aged 14--19 years, approximately 0.8% reported using CM in the past 12 months in 2016; this increased to 3.0% for young people aged 20--29 years \[[@pone.0229389.ref003]\]. Less information is available about the prevalence of lifetime CM use although estimates of up to 4.0% have been reported for young people aged 15 to 29 years in Australia \[[@pone.0229389.ref010]\]. More than half of methamphetamine users in Australia use CM \[[@pone.0229389.ref003]\]. CM users are also more likely to use on a regular basis compared with users of other forms of methamphetamine \[[@pone.0229389.ref003]\].

Adolescence is an important phase of neuro-development, with the brain still maturing and developing \[[@pone.0229389.ref011],[@pone.0229389.ref012]\]. For this reason, and the deleterious psychological effects of CM use, CM use during adolescence may have serious long-term psychiatric and neurological consequences. A number of studies have investigated the correlates of adolescent methamphetamine use. Associations have been reported between adolescent methamphetamine use and psychiatric symptomatology \[[@pone.0229389.ref013]--[@pone.0229389.ref016]\], antisocial behaviour \[[@pone.0229389.ref015]--[@pone.0229389.ref017]\], risky sexual practices \[[@pone.0229389.ref017]\], polysubstance use \[[@pone.0229389.ref016]\], interaction with antisocial peers \[[@pone.0229389.ref014],[@pone.0229389.ref017]\], peer drug use \[[@pone.0229389.ref014],[@pone.0229389.ref017]\], and violence perpetration \[[@pone.0229389.ref016]\].

Links between CM use and criminal offending are often drawn in the media \[[@pone.0229389.ref018]--[@pone.0229389.ref020]\]; however, there has been little scientific research into this relationship. Again, the research has focused on methamphetamine use more broadly. Several studies have found that young methamphetamine users commit both violent and non-violent criminal offences, with lifetime prevalence estimates ranging from 35%--55% of users committing crime \[[@pone.0229389.ref021]--[@pone.0229389.ref024]\]. However, after reviewing these studies, McKetin et al. \[[@pone.0229389.ref025]\] speculated that the rates of involvement in violent crime for methamphetamine users are likely similar to rates of violent crime among users of other substances.

To our knowledge, only one study has specifically examined the relationship between CM use and violent recidivism in adolescence. Iritani et al. \[[@pone.0229389.ref004]\] examined the association between CM use and criminal charges for 14,322 young adults in the United States. After controlling for socio-demographic variables and the use of other substances, the authors found that the association between CM use and criminal charges was not significant.

Given recent increases in CM use among young people in Australia, there is a clear need for further research exploring the relationship between CM use and violence in adolescent populations. This is especially true for at-risk or vulnerable groups such as young people in juvenile detention. Several studies have reported higher rates of substance use \[[@pone.0229389.ref026]--[@pone.0229389.ref028]\] and psychiatric symptomatology \[[@pone.0229389.ref029]--[@pone.0229389.ref032]\] for young people in detention relative to the age-matched general population. However, no studies to date have investigated CM use specifically among young people in detention. If CM use is associated with repeat violent recidivism, then this has ramifications for risk management and reducing recidivism. CM use in this population is also a significant health concern, given the association between CM use and adverse psychiatric and health outcomes \[[@pone.0229389.ref003]--[@pone.0229389.ref006]\]. This study aimed to address this substantial gap in knowledge by seeking to identify 1) the lifetime prevalence of CM use, 2) the correlates of CM use, and 3) the association between CM use and future violent criminal offending, among a sample of young people in detention.

Materials and methods {#sec002}
=====================

Settings {#sec003}
--------

Participants were recruited from both youth justice centres in Victoria, Australia. The first, Parkville Youth Justice Precinct (PYJP), accommodates males and females aged from 10 to 17 years, and young women aged 18 to 20 years, who have been remanded or sentenced in a Victorian court. The second, Malmsbury Youth Justice Centre (MYJC), accommodates young men aged 18 to 20 years who have been remanded or sentenced in a Victorian court.

Procedure {#sec004}
---------

Participants were eligible to participate if they were English speaking and able to comprehend the participatory explanation form. Detainees were not approached if Justice Centre staff deemed them to be of unstable mood or likely to exhibit extreme aggressive behavior if interviewed. Consenting participants were then administered a semi-structured interview in custody by masters level clinical psychology researchers. The interview canvassed prior self-reported delinquent behaviour and initiation into criminal activity, peer/family relationships, attitudes towards offending, traumatic experiences, mental health symptoms, and education/employment involvement. The interview responses were used to code the Structured Assessment of Violence Risk in Youth (SAVRY) risk instrument (described below). Participants were interviewed individually in private rooms allocated by youth justice custodial centre staff. The duration of each assessment was approximately 90 minutes.

Ethics, Consent and Permissions {#sec005}
-------------------------------

Written informed consent was obtained from all participants prior to the interview commencing. Parental consent was not obtained. Consent for participants under 18 years of age fell within the "mature minor" concept as described in Australian case law \[[@pone.0229389.ref033]\], where mental competency is determined by the ability of an underage participant to understand or appreciate information pertaining to their partaking in, and the nature of, the study. No participants were determined to lack the capacity to provide informed consent and no participants refused to provide informed consent. The study was approved by the Victorian Department of Human Services and the Monash University Human Research Ethics Committee (CF10/2960--2010001629).

Measures {#sec006}
--------

Measures of CM use, other substance use, past psychiatric diagnosis, and the Structured Assessment of Violence Risk in Youth (SAVRY), were administered at baseline. Violent recidivism during the subsequent 18 months was assessed through prospective linkage with state-wide police records.

Crystalline methamphetamine (CM) use {#sec007}
------------------------------------

Participants were asked if they had ever used CM. Colloquial Australian terms for CM such as 'ice' or 'shards' were included in the questioning. Responses were coded into a binary variable (0 = No CM use; 1 = lifetime CM use).

Other substance use {#sec008}
-------------------

The Kiddie Schedule for Affective Disorders and Schizophrenia Present---Lifetime Version (KSADS-PL) is a semi-structured interview schedule designed to screen for a range of psychological disorders in children and adolescents \[[@pone.0229389.ref034]\]. It comprises six sections and five diagnostic supplements. Diagnostic supplement 5 --Substance Abuse and Other Disorders--was used in the present study. This supplement contains questions concerning lifetime use of a number of illicit substances, and frequency of alcohol use per month. Each item relating to lifetime use of an illicit substance is scored from 0--2 (0 indicating 'no information', 1 indicating 'no use', and 2 indicating 'substance use'). Frequency of alcohol use is scored by recording the number of days per month a respondent reports using alcohol on average. The KSADS-PL Diagnostic supplement 5 items used in the present study covered lifetime use of cannabis, sedatives/hypnotics/anxiolytics, opioids, hallucinogens, cocaine and solvents/inhalants; and frequency of alcohol use per month.

Psychiatric diagnosis {#sec009}
---------------------

Data on the presence of any past psychiatric diagnosis was obtained from the state-wide public mental health database, known as the Redevelopment of Acute and Psychiatric Information Directions (RAPID). Diagnoses are recorded by health workers in the public mental health system through the client management interface under mandatory requirements specified under the Australian Health Care Agreement \[[@pone.0229389.ref035]\]. A diagnosis was considered present if a participant had a registered diagnosis of anxiety disorder (ICD codes: F41.1, F41.9, F42.0, F93.0), mood disorder (ICD-10 codes: F31.1, F31.8, F33, F34.1), schizophrenia (ICD-10 codes: F20.9, F21, F25.9), psychosis (ICD-10 codes: F29, F10.95, F11.95, F12.95, F13.95, F14.95, F15.95, F16.95, F18.95, F19.95), trauma associated disorder (ICD-10 codes: F43.10, F43.2, F43.8), personality disorder (ICD-10 codes: F60.2, F60.3, F60.9), behavioural disorder (F63, F91.3, F91.9,), or a neuro-developmental disorder (ICD codes: F70, F71, F72, F73, F78, F79, F81.9, F89, F90.9, F299.0, Q86.0). Given the low proportion of participants across diagnostic categories, a decision was made to create a binary variable indicating the presence of any diagnosis (0 = No diagnosis present; 1 = Any diagnosis present)

Structured Assessment of Violence Risk in Youth (SAVRY) {#sec010}
-------------------------------------------------------

The SAVRY is a structured professional judgment instrument designed to assess risk for violence in young people aged 12--18 years \[[@pone.0229389.ref036]\]. It comprises 24 risk items across three subscales assessing Historical, Socio/Contextual, and Individual domains. Each SAVRY risk item is coded on a three-point scale (0 = Low, 1 = Moderate, 2 = High) to indicate the presence and severity of the risk item.

For the purposes of the present study, four SAVRY items that had shown previous empirical and/or theoretical relationships with CM use were selected to test for an association between CM use and violence risk in the sample. These were:

a\) Lifetime history of violence (Low = no acts of violence, Moderate = 1 to 2 acts of violence; High = 3 or more acts of violence);

b\) peer delinquency (Low = Youth does not associate with delinquent peers, Moderate = Youth occasionally associates with other delinquents or criminals or regularly associates with other youth who have engaged in relatively infrequent or minor antisocial acts, High = Youth frequently associates with other delinquents or criminals, including other youth who regularly engage in antisocial acts and/or youth is involved with gang activities or is a gang member);

c\) community disorganisation (Low = Youth lives in a community with low rates of crime, poverty and violence, Moderate = Youth lives in a community with some problems related to higher rates of crime, poverty, and/or violence, High = Youth lives in a community with significant problems relating to high rates of crime, poverty, and/or violence);

d\) Poor parental management (Low = Youth is receiving consistent and appropriate parental discipline, adequate supervision and involvement by parents, Moderate = Youth is receiving discipline that is sometimes inconsistent, but not overly strict or overly permissive on a regular basis; High = Youth is receiving discipline that is extremely inconsistent, or that is consistently overly strict or overly permissive).

Subsequent violent recidivism {#sec011}
-----------------------------

Follow-up data were collected for up to 18 months post-interview. All participants had a minimum of six months follow up time. Participants consented to allow Victoria Police to release their de-identified criminal history from Victoria Police (i.e., the Law Enforcement Assistance Program) database to the research team. In line with the World Health Organisation's definition of violence \[[@pone.0229389.ref037]\], we defined violent recidivism as incorporating both intentional physical harm and threats to cause physical harm.

Police charges were selected for the outcome rather than arrests or convictions. We reasoned that arrests might underestimate violent recidivism given that not all violent offences result in arrest. We also decided against using convictions given a) the likely low base rate of conviction over the limited follow up period and the likely underestimate of violent recidivism caused by decisions not to proceed to trial.

In order to create a de-identified dataset, a statistical linkage key was used which linked names and birth dates of participants with a unique code. The linkage key was stored separately from the matched dataset.

Statistical analysis {#sec012}
--------------------

We calculated the percentage (with 95% confidence intervals) of participants who reported using each of the following substances: CM, cannabis, sedatives/hypnotics/anxiolytics, opioids, hallucinogens, cocaine, and solvents/inhalants. In addition, a polysubstance use score was calculated by summing the number of substances that participants reported using (not including CM) and dichotomising the variable into those who had and had not used two or more substances (polysubstance use).

Multivariate logistic regression models were constructed to estimate associations between independent variables and CM use (model 1) and independent variables and violent recidivism (models 2 and 3). Given the large number of terms in each model relative to events in the outcome variable, each model was penalized to reduce overfitting and overestimates of associations \[[@pone.0229389.ref038]\]. Penalty terms were chosen using the Pentrace function in the RMS package \[[@pone.0229389.ref039]\], which determines the optimum penalty term by constructing multiple models with differing penalty terms and selecting the penalty term that results in best model fit (as determined by the Akaike information criterion). Penalty terms used in each of the models were model 1 = 0.5; model 2 = 34.7; model 3 = 10.4.

Model 1 aimed to identify correlates of CM use. Potential correlates were selected based on associations reported in previous literature \[[@pone.0229389.ref004],[@pone.0229389.ref012]--[@pone.0229389.ref016]\] and included demographic variables (age and sex), substance use variables (frequency of alcohol use, and polysubstance use), and social variables (psychiatric diagnosis to baseline, community disorganization, and poor parental management). Odds ratios (ORs) and associated 95% confidence intervals (95%CI) were computed for each variable, first unadjusted and then adjusted for all other variables in the model.

The relationship between CM use and subsequent violent recidivism was then assessed through two multivariate logistic regression models. Using a single model for all variables was not possible due to the relatively small sample size. Model 2 examined the relationship between lifetime use of various substance classes (including CM) and violent recidivism. The second examined the association between CM use and violent recidivism together with polysubstance use, psychiatric diagnosis, and history of violence. For each of the significance tests performed in the current study, the alpha level was set at .05 and all tests were two-tailed.

Results {#sec013}
=======

Sample {#sec014}
------

A total of 202 (*male* = 164 \[81%\]) young people consented to take part in the study. This represents a considerable recruitment faction given that population estimates suggest that within the state of Victoria, the number of young people in detention on an average night ranged from 143 to 182 from 2011 to 2013, with an average of 157 young peple in detention on an average night in the time period of recruitment\[[@pone.0229389.ref040]\]. The mean age of participants was 16.7 (*SD* = 1.8, range: 12--21) years. The majority (86%, *n* = 174) had previously been charged by police for a violent offence and all participants had a self-reported history of violence. The most common index offence in the cohort was serious assault (33%, *n* = 49).

Prevalence of crystalline methamphetamine use {#sec015}
---------------------------------------------

The prevalence of lifetime use of CM and other substances is presented in [Table 1](#pone.0229389.t001){ref-type="table"}. Cannabis (86%) was the substance most commonly used in the sample, followed by CM (38%). All participants who reported using CM also reported polysubstance use. Polysubstance use was reported by 33% (n = 65) of the sample.

10.1371/journal.pone.0229389.t001

###### Lifetime substance use prevalence and associated 95% confidence intervals.

![](pone.0229389.t001){#pone.0229389.t001g}

  Substance                                                 n/N       \%   (95% CI)
  --------------------------------------------------------- --------- ---- ----------
  Cannabis                                                  172/200   86   80, 90
  Crystalline Methamphetamine                               76/202    38   31, 45
  Sedatives/Hypnotics/Anxiolytics                           35/199    18   13, 24
  Opioids                                                   31/200    16   11, 21
  Hallucinogens                                             19/200    10   6, 15
  Cocaine                                                   18/200    9    6, 14
  Solvents/Inhalants                                        18/200    9    6, 14
  Polysubstance use[^a^](#t001fn001){ref-type="table-fn"}   65/198    33   26, 40

^a^Polysubstance use did not include CM use.

CM use was reported by 57% (n = 37) of participants who reported polysubstance use. Those who reported using CM reported having used, on average, one substance other than CM (median = 1, range = 0--6). The number of additional substances reported by those who had not used CM was similar (median = 1, range = 0--5). The substance most frequently co-reported with CM use was cannabis (n = 72, 95%). A small proportion of the sample (n = 20, 10%) had not used any of the substances listed.

Correlates of crystalline methamphetamine use {#sec016}
---------------------------------------------

A multivariate logistic model was constructed to identify correlates of CM use in the sample. Nagelkerke's R^2^ for the model was R^2^ = 0.42.

Four variables were significantly associated with CM use in the adjusted model: older age, male gender, polysubstance use, and high community disorganisation ([Table 2](#pone.0229389.t002){ref-type="table"}).

10.1371/journal.pone.0229389.t002

###### Correlates of crystalline methamphetamine use.

![](pone.0229389.t002){#pone.0229389.t002g}

                                                            No CM Use (N = 123)   CM Use (N = 75)                                                                                              
  --------------------------------------------------------- --------------------- ----------------- -------- ---- ---- ---------- ------------------------------------------------------------ ------------------------------------------------------------
  Age (per year older)                                      \-                    \-                \-       \-   \-   \-         1.3 (1.1, 1.5)[\*\*](#t002fn003){ref-type="table-fn"}        1.3 (1.1, 1.6)[\*\*](#t002fn003){ref-type="table-fn"}
  Female                                                    34                    28                20, 37   1    1    1\<, 8     ref                                                          ref
  Male                                                      89                    72                63, 80   74   99   92, \>99   28.3 (3.8, 211.5)[\*\*\*](#t002fn004){ref-type="table-fn"}   25.5 (5.6, 117.2)[\*\*\*](#t002fn004){ref-type="table-fn"}
  No polysubstance use                                      95                    77                69, 84   38   51   39, 62     ref                                                          ref
  Polysubstance use[^a^](#t002fn001){ref-type="table-fn"}   28                    23                16, 31   37   49   38, 61     3.3 (1.8, 6.1)[\*\*\*](#t002fn004){ref-type="table-fn"}      4.7 (2.2, 10.1)[\*\*\*](#t002fn004){ref-type="table-fn"}
  Frequency of alcohol use (days per month)                 \-                    \-                \-       \-   \-   \-         1.0 (1.0, 1.2)                                               1.0 (0.9, 1.0)
  No psychiatric diagnosis                                  72                    59                49, 67   53   71   59, 80     ref                                                          ref
  Psychiatric diagnosis                                     51                    41                33, 51   22   29   20, 41     0.6 (0.3, 1.1)                                               0.6 (0.3, 1.2)
  Low community disorganisation                             47                    38                30, 47   16   21   13, 33     ref                                                          ref
  Mod. community disorganisation                            38                    31                23, 40   22   29   20, 41     1.7 (0.8, 3.7)                                               2.3 (0.9, 5.9)
  High community disorganisation                            37                    31                22, 39   37   49   38, 61     2.9 (1.4, 5.9)[\*\*](#t002fn003){ref-type="table-fn"}        6.3 (2.4, 16.6)[\*\*\*](#t002fn004){ref-type="table-fn"}
  Low peer delinquency                                      6                     5                 2, 11    4    5    2, 13      ref                                                          ref
  Mod. peer delinquency                                     37                    30                22, 39   12   16   9, 27      0.5 (0.1, 2.0)                                               0.4 (0.1, 1.7)
  High peer delinquency                                     80                    65                56, 73   59   79   67, 87     1.1 (0.3, 4.1)                                               0.5 (0.1, 2.2)
  Low poor parental management                              20                    16                10, 24   11   15   8, 25      ref                                                          ref
  Mod. poor parental management                             39                    32                24, 41   22   29   20, 41     1.0 (0.4, 2.5)                                               0.9 (0.3, 2.7)
  High poor parental management                             64                    52                43, 61   42   56   44, 67     1.2 (0.5, 2.7)                                               1.1 (0.4, 3.0)

^a^Polysubstance use did not include CM use

\*p \< .05

\*\*p \< .01

\*\*\*p \< .001

Association between crystalline methamphetamine use and subsequent violent recidivism {#sec017}
-------------------------------------------------------------------------------------

During the follow up period, just over half of the sample were charged with a violent offence (n = 103, 51.0%), with 52 (25.7%) being charged within two months of release.

The association between CM use and violent recidivism was examined in two multivariate logistic regression models. The first model examined the association between use of various substances, including CM, and violent recidivism. The second model examined the association between CM use, polysubstance use, presence of a psychiatric diagnosis, history of violence, and subsequent violent recidivism.

Nagelkerke's R^2^ for model 1 was R^2^ = 0.02 and for model 2 R^2^ = 0.17.

The associations between substance use and violent recidivism are presented in [Table 3](#pone.0229389.t003){ref-type="table"}. None of the variables entered into the model was significantly associated with violent recidivism (all p \> .05).

10.1371/journal.pone.0229389.t003

###### Association between substance use and subsequent violent recidivism.

![](pone.0229389.t003){#pone.0229389.t003g}

                                              No Recidivism (N = 58)   Recidivism (N = 102)                                                 
  ------------------------------------------- ------------------------ ---------------------- -------- ---- ---- -------- ----------------- ----------------
  No CM                                       36                       62                     48, 74   62   61   51, 70   ref               ref
  CM                                          22                       38                     26, 52   40   39   30, 49   1.1 (0.5, 2.0)    1.0 (0.7, 1.5)
  No Cannabis                                 7                        12                     5, 24    15   15   9, 23    ref               ref
  Cannabis                                    51                       88                     76, 95   87   85   77, 91   0.8 (0.3, 2.1)    1.1 (0.7, 1.6)
  No Sedatives                                52                       90                     78, 96   80   78   69, 86   ref               ref
  Sedatives                                   6                        10                     4, 22    22   22   14, 31   2.4 (0.9, 6.3)    1.2 (0.8, 1.8)
  No Cocaine                                  50                       86                     74, 93   94   92   85, 96   ref               ref
  Cocaine                                     8                        14                     7, 26    8    8    4, 15    0.5 (0.2, 1.5)    0.9 (0.6, 1.4)
  No Opioid use                               51                       88                     76, 95   83   81   72, 88   ref               ref
  Opioid use                                  7                        12                     5, 24    19   19   12, 28   1.7 (0.7, 4.2)    1.1 (0.7, 1.7)
  No hallucinogens                            53                       91                     80, 97   92   90   82, 95   ref               ref
  Hallucinogens                               5                        9                      3, 20    10   10   5, 18    1.2 (0.4, 3.6)    1.0 (0.6, 1.5)
  No solvents                                 56                       97                     87, 99   89   87   79, 93   ref               ref
  Solvents                                    2                        3                      1, 13    13   13   7, 21    4.1 (0.9, 18.9)   1.2 (0.8, 1.8)
  Frequency of alcohol use (days per month)   \-                       \-                     \-       \-   \-   \-       1.0 (0.9, 1.1)    1.0 (0.9, 1.0)

^a^ Odds ratios are adjusted for all other variables listed in the model.

[Table 4](#pone.0229389.t004){ref-type="table"} presents the associations between CM use, polysubstance use, the presence of a psychiatric diagnosis, a history of violence, and subsequent violent recidivism. Of the terms included in the model, only the presence of a psychiatric diagnosis was significantly associated with violent recidivism (AOR = 1.8, 95% CI 1.0--3.4). Four interaction terms were also included in the model, however none of them was significantly associated with the outcome.

10.1371/journal.pone.0229389.t004

###### Associations between mental health, polysubstance use history of violence, CM use and violent recidivism.

![](pone.0229389.t004){#pone.0229389.t004g}

                                                            No offending (N = 58)   offending (N = 102)                                                                                         
  --------------------------------------------------------- ----------------------- --------------------- -------- ---- ---- -------- --------------------------------------------------------- -----------------------------------------------------
  No CM use                                                 36                      62                    48, 74   62   61   51, 70   ref                                                       ref
  CM use                                                    22                      38                    26, 52   40   39   30, 49   1.1 (0.5, 2.0)                                            1.1 (0.6, 2.3)
  No polysubstance use                                      42                      72                    59, 83   63   62   52, 71   ref                                                       ref
  Polysubstance use[^a^](#t004fn001){ref-type="table-fn"}   16                      28                    17, 41   39   38   29, 48   1.6 (0.8, 3.3)                                            1.3 (0.6, 2.6)
  Low/moderate history of violence                          12                      21                    12, 34   21   21   13, 30   ref                                                       ref
  High history of violence                                  46                      79                    66, 88   81   79   70, 87   1.0 (0.5, 2.2)                                            0.9 (0.5, 1.7)
  No psychiatric diagnosis                                  45                      78                    64, 87   52   51   41, 61   ref                                                       ref
  Psychiatric diagnosis                                     13                      22                    13, 36   50   49   39, 59   3.3 (1.6, 6.9)[\*\*\*](#t004fn005){ref-type="table-fn"}   1.8 (1.0, 3.4)[\*](#t004fn003){ref-type="table-fn"}
  CM use \* Psychiatric diagnosis                           \-                      \-                    \-       \-   \-   \-       \-                                                        1.1 (0.4, 3.1)
  CM use \* History of violence                             \-                      \-                    \-       \-   \-   \-       \-                                                        0.8 (0.4, 1.9)
  Polysubstance use \* History of violence                  \-                      \-                    \-       \-   \-   \-       \-                                                        0.9 (0.4, 2.2)
  Polysubstance use \* Psychiatric diagnosis                \-                      \-                    \-       \-   \-   \-       \-                                                        2.1 (0.6, 7.1)

^a^Polysubstance use did not include CM use

^b^ Odds ratios are adjusted for all variables listed in the model

\*p \< .05

\*\*p \< .01

\*\*\*p \< .001

Given that the variable for psychiatric diagnosis was considerably heterogeneous in terms of diagnoses included, a sensitivity analysis was conducted with four homogenous sub-groups of diagnoses--mood disorders, behavioural disorders, anxiety disorders, trauma related disorder. Three of the four categories examined for participants who re-offended---mood disorders (21.4%), behavioural disorders (28.2%), and trauma related disorder (23.3%)---were present at similar rates among those who were subsequently charged with a violent offence in the follow up period. Diagnoses of anxiety disorders were present at a slightly lower rate among participants who re-offended (17.5%).

Discussion {#sec018}
==========

This study is the first internationally to examine the prevalence and correlates of crystalline methamphetamine (CM) use in a sample of young people released from juvenile detention. We also examined the association between CM use and violent recidivism.

Prevalence of CM use {#sec019}
--------------------

More than one third of participants reported lifetime CM use. Rates of substance use are often much higher in youth justice populations\[[@pone.0229389.ref026],[@pone.0229389.ref027]\], but the high prevalence of CM use in this sample compared to the general Australian population (estimates range from 3--4%, \[[@pone.0229389.ref003],[@pone.0229389.ref010]\]) is particularly striking. The lifetime prevalence of use of other substances (e.g., cannabis, 86%) in this sample was also considerably higher than in the general population. One third of the sample had previously used two or more of the substances we examined and, of these, more than half (57%) had also used CM. We were unable to determine whether CM use preceded or succeeded the use of other illicit drugs. Given that in the general population the mean age for first use of cannabis is typically lower than mean age for first use of CM \[[@pone.0229389.ref003]\], it is likely that CM was not the first substance ever used by participants. Previous reports indicate that CM users often consume additional drugs and engage in risky drinking behaviour \[[@pone.0229389.ref003]\]. The high rates of polysubstance use reported in our study highlight a major area of therapeutic need for youth custodial populations.

Correlates of CM use {#sec020}
--------------------

Consistent with evidence from the general population that age at first use of methamphetamines is higher than for some other substances such as cannabis \[[@pone.0229389.ref003]\], we found that older participants were more likely to report a history of CM use. We also found that young males were more than 25 times more likely than young females to report CM use, suggesting a gendered nature of CM use in this population. Our findings are consistent with prior research with young people (aged 15--29) in Australia, which found that both being male and older age were associated with CM use\[[@pone.0229389.ref010]\]. Similarly, an Australian study investigating the characteristics of CM users presenting to a hospital emergency department found the cohort to be predominantly male and between the ages of 26--30 years\[[@pone.0229389.ref008]\].

We also found that polysubstance use was associated with CM use. This finding was anticipated given that more than half of the participants who reported lifetime CM use also reported using other substances. CM, at least for members of this cohort, is perhaps seldom used in isolation and may be consumed by those who already have histories of illicit drug use. A recent Australian study of 564 people who inject drugs found that only a small percentage of the cohort reported CM as the substance most used over the past month\[[@pone.0229389.ref041]\].

Participants who reported living in a community with high levels of disorganisation were almost six times more likely than participants from communities with low levels of disorganisation to have used CM. The SAVRY operationalisation of this item refers to communities with high rates of crime, poverty and violence. Such communities often have a higher availability of illicit drugs. Moreover, research from Australia suggests a greater of availability of CM in the community in recent years\[[@pone.0229389.ref042]\]. Associations have been drawn between neighbourhood factors (i.e., disadvantage, high-crime rates, instability, disorganization, perceived drug selling) and youth substance use \[[@pone.0229389.ref043]--[@pone.0229389.ref047]\]. Having friends who use illicit substances is also linked with substance use\[[@pone.0229389.ref003],[@pone.0229389.ref048]\]. The associations found between community disorganisation and substance use among justice involved young people point to the importance of broader community based strategies to reduce CM use among this vulnerable population following their release from detention.

CM use and violent recidivism {#sec021}
-----------------------------

Over a span of 13 months, more than half of the sample was charged with at least one violent offence. We found no association between use of CM or any other substance and violent recidivism; however, a history of psychiatric diagnosis was associated with violent recidivism. The association between mental disorder and recidivism is consistent with previous research on youth custodial populations, with several studies reporting high rates of mental disorder among this population \[[@pone.0229389.ref029]--[@pone.0229389.ref031],[@pone.0229389.ref049]\] and an association with future recidivism \[[@pone.0229389.ref050]\].

Research examining the relationship between psychiatric diagnoses and violent recidivism in this population has pointed to the fact that common symptoms of psychiatric illnesses such as substance use, impulsivity and irritability (as related to substance use disorders and attention deficit disorders for example) are also common risk factors for violent recidivism\[[@pone.0229389.ref051],[@pone.0229389.ref052]\]. While a causal relationship has not been established between symptomology and violent recidivism, the relationship appears to suggest that treatment of mental health symptoms could have utility in reducing violent recidivism. These findings highlight the importance of adequate investment in evidence-based, continuous and coordinated mental health care for young people who cycle through youth detention, as a means of reducing violent recidivism.

Limitations {#sec022}
-----------

This is the first study to examine correlates of CM use among detained youth, however it had a number of limitations. Firstly, we examined only lifetime use of CM and did not include measurements of frequency of use, use within a specified period (e.g., past 12 months), or estimates of typical quantity used. However, given the relatively young age of the sample, it is likely that only a minority had ceased using substances for which they reported lifetime use. Furthermore, the study relied entirely on self-report measurements of CM use. While self-report is a useful method of measuring CM use, it is vulnerable to failures of memory and reticence to answer sensitive questions relating to drug use. Ideally, future research would incorporate data from other sources (e.g., linked drug treatment or hospital records, urinalysis) to triangulate measurement of CM use in this population. Finally, the modest sample size limited statistical power, and although we had a high recruitment fraction it was not possible to formally assess sample representativeness. Our estimates of prevalence and association will require replication in larger samples.

Implications and conclusions {#sec023}
----------------------------

Our study provides further evidence that rates of lifetime substance use are substantially higher among young people in detention than in the general population \[[@pone.0229389.ref026],[@pone.0229389.ref027]\]. Given the established associations between substance use and adverse psychiatric and physical health outcomes, there is a clear need for processes to identify and support detained youth who have or are at-risk of developing substance use problems. Identification should involve not only drug testing, but also the use of interviews and screening measures that can inform treatment responses, both in detention and after these young people return to the community.

Although there is good evidence that CM use is associated with poor health outcomes \[[@pone.0229389.ref004]--[@pone.0229389.ref009]\], in this study neither CM use nor use of other substances was associated with violent recidivism. The assessment of violence risk is an area of increasing importance for health professionals operating in youth detention settings, and also for corrections staff. While our findings suggest that CM use was not associated with violent recidivism, the measurement of CM use was not sensitive to the frequency and extent of CM use. It is quite possible that an association between CM use and violent recidivism exists when taking into account a more nuanced measurement. More detailed assessment of the relationship between CM use and violent recidivism, taking into account factors like method of administration, frequency of use and average amount of use may uncover important relationships that ought to be considered in determining which young people should be selected for treatment designed to reduce risk of violent recidivism.

10.1371/journal.pone.0229389.r001
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Dear Dr Shepherd,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

I have read the paper and agree with the reviewers that it makes a useful contribution to limited evidence in this important area. The study is methodological sound with the use of linkage data however I felt it was lacking in detail in several areas (e.g., in relation to the databases used). I believe addressing this would strengthen the paper given the international readership of this journal.

The abstract needs to be clearer in the results section that CM was not associated with re-offending (i.,e., post-release) as this was one of the 2 main aims of the study.

Please add ethics approval reference

More information is needed on how mental health diagnoses are made, i.e., how they get recorded in RAPID. It may also be worth noting in the limitations section that these may an underestimate if they had mental health issues that had gone undetected/not diagnosed. Similarly how were de-identified records examined with Victoria Police) - was there a statistical linkage key used?

Please clarify why violent offending data time period was so variable - up to 18 months is reported in the method but the range indicated in the results sections suggests it was as early as 1-month for some - surely this would limit the chances of there being a reported offence?

The discussion could go further in unpacking the demonstrated relationship between psychiatric diagnosis and reoffending (e.g., poor impulse control, lack of insight etc).

I also think the paper would benefit from my consistent methodology - (recidivism, re-offending, future violent criminal offending).

We would appreciate receiving your revised manuscript by Mar 13 2020 11:59PM. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Victoria Manning

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1\. Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at

<http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and <http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

2\. Please provide additional information regarding the considerations made for the prisoners included in this study.

For instance, please discuss whether participants were able to opt out of the study and whether individuals who did not participate receive the same treatment offered to participants.

Please specifically clarify whether consent procedures were approved by IRB

3\. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study\'s minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see <http://journals.plos.org/plosone/s/data-availability>.

Upon re-submitting your revised manuscript, please upload your study's minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see <http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories>. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: <http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions>. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

4\. Thank you for stating the following in the Declarations Section of your manuscript:

\'Funding

This research was funded by the Australian Research Council -- grant number DP1095697\'

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

\'This study was funded by the Australian Research Council ([www.arc.gov](http://www.arc.gov).au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.\'

Please provide an amended Funding Statement that declares \*all\* the funding or sources of support received during this specific study (whether external or internal to your organization) as detailed online in our guide for authors at <http://journals.plos.org/plosone/s/submit-now> Please state what role the funders took in the study.  If any authors received a salary from any of your funders, please state which authors and which funder. If the funders had no role, please state: \"The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.\"

c\. Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

5\. Your ethics statement must appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please also ensure that your ethics statement is included in your manuscript, as the ethics section of your online submission will not be published alongside your manuscript.

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Partly

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: No

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: No

Reviewer \#2: No

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: This study sought to identify (a) the lifetime prevalence of crystalline methamphetamine (CM) use, (b) the correlates of CM use, and (c) the association between CM use and future violent criminal offending among a sample of young people in detention. The participants were 202 young people in youth detention in the state of Victoria, Australia. Results revealed that more than one-third of the sample (38%) reported lifetime CM use, with older age, male gender, polysubstance use, and high levels of community disorganization being associated with CM use. The presence of a psychiatric diagnosis over the lifetime was not significantly associated with CM use, and CM use was not significantly associated with violent offending.

Given the media attention focused on the perceived relationship between CM use and offending, particularly violent offending, an empirical investigation of the relationship has obvious scientific merit. The authors should therefore be commended for undertaking this research. This study has several strengths, including a convincing rationale, a clear design and methodology, straightforward statistical analyses, and a solid synthesis of the results with the existing literature. I also appreciated the use of precise language that did not imply causality. Despite these strengths, there are several notable methodological limitations and several aspects of the manuscript in need of attention.

\(1\) The likely lack of generalizability of the study findings is a significant concern, particularly in light of the stated goals of the study. The sample size is relatively small (N = 202), with an even smaller subset (n = 76) who reported lifetime CM use. Also, the sample was drawn from two youth justice facilities in one Australian state. The small, geographically limited sample raises concerns that the sample may not be representative. The manuscript appropriately acknowledged that "it was not possible to formally assess sample representativeness" (see Limitations), but it is difficult to overlook this limitation. A stated study goal was to assess lifetime prevalence use of CM, but to do so in a meaningful and defensible manner requires a larger, representative sample.

\(2\) The manuscript indicates that informed consent was obtained from all participants over age 18, and that consent for participants under age 18 fell within the "mature minor" concept. However, there is no indication of whether anyone refused to provide informed consent, or whether any of the participants under age 18 were determined to lack the capacity to understand the nature of the study.

\(3\) A related concern is the lack of information regarding the recruitment fraction. The manuscript states that the authors achieved a "high recruitment fraction" (see Limitations), but no other information is provided. As such, it is not possible to assess whether the sample size of 202 is a small, moderate, or large sample of the population of interest. Providing the census of the two facilities would be informative.

\(4\) The use of a binary variable for CM use (0 = no CM use; 1 = lifetime CM use) lacks sufficient specificity and sensitivity. When addressing this limitation, the manuscript stated: "Firstly, we examined only lifetime use of CM and did not include measurements of frequency of use, use within a specified period (e.g., past 12 months), or estimates of typical quantity used" (see Limitations). Acknowledging this limitation is laudable, but it is difficult to overlook. Given the binary nature of this variable, participants who used CM once are grouped with participants who used CM many times. Such a crude classification system does not acknowledge the differences that (likely) exist between those with limited CM use and those with extensive CM use; grouping them together adds too much noise to the data, and the study results pertaining to CM use, the relationship between CM use and other drug use, and the relationship between CM use and violence become less defensible and less meaningful. For example, concluding that more than one-third of the sample reported lifetime CM use could be misleading because we do not know what proportion of those participants used CM once versus many times. To be clear, using CM once is indeed lifetime CM use, but it may not make sense (given what we know about episodic versus chronic CM use) to group one-time CM users with chronic CM users.

\(5\) There is a similar sensitivity problem related to the definition of violent offending. The manuscript defined violent recidivism as "any personal injury transgression that led to a police charge," which included "acts intended to cause or threaten to cause physical harm to a victim." There are two concerns. First, defining recidivism based on charges, as opposed to arrests or convictions, would benefit from being justified. Second, combining acts with threats introduces noise into the data because there are differences between acts of violence and threats of violence. Some justification for combining acts and threats would strengthen the manuscript.

\(6\) The manuscript does not include an a priori statistical power analysis. The manuscript mentions that the "modest sample size limited statistical power," but (a) it is not clear how the authors know that statistical power was in fact limited, and (b) the lack of a power analysis (and potentially low power) raises concerns about Type II errors.

\(7\) The manuscript does not include any testable hypotheses.

\(8\) To support the assertion that the adolescent brain is still developing, the manuscript cites an article from 1999. The 1999 article is certainly a solid reference, but perhaps a more recent reference that reflects the current brain science would be more informative.

Thank you for the opportunity to review this manuscript.

Reviewer \#2: This study reports on the association between a lifetime history of methamphetamine use and violent offending in a prospective study of people in youth detention. No previous studies have examined this relationship longitudinally in this population (see recent systematic review by McKetin et al in eClinicalMedicine 16: 87-91).

The main weakness of the present study is the exposure measure (any lifetime use) lacks the ability to differentiate between people who have used frequently and those with only occasional use. Its main strength is the used of linkage data for the outcome. The methods and results are clearly written, and the analytic approach appears sound.

Comments are minor:

1\. Section 2.1 needs more information about the sampling frame & sampling strategy- how were participants selected?

2\. Regarding the associations between having a psychiatric diagnosis and violent recidivism, is it possible this could be explained by reverse causation- that is, violent offences led to psychiatric assessment which then resulted in a diagnosis being recorded?

3\. The comment "Our findings suggest that CM use on its own is unlikely to be an important consideration" etc over-reaches what this study shows, since it's possible the association with violence is confined to people who have used CM frequently (see Foulds et al- "Methamphetamine use and violence: findings from a longitudinal birth cohort"- Drug and Alcohol Dependence, in press). Thus an alternative conclusion would be that more detailed assessment of CM use- ie frequency, route of administration and presence of substance use disorder- is necessary to aid treatment selection. Though it is noted that no evidence-based treatments specific to methamphetamine use disorder exist at this time.

4\. In Table 2, 3 and 4 the inclusion of rows for the reference categories (eg "no cannabis") is perhaps not necessary. Consider omitting the reference category rows unless these are essential to the data presentation.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: Yes: James Foulds

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Editors' comments

The abstract needs to be clearer in the results section that CM was not associated with re-offending (i.,e., post-release) as this was one of the 2 main aims of the study.

Thank you for pointing out this omission. We have revised the abstract to include this information.

Please add ethics approval reference

The ethics approval number has now been added to the method section

More information is needed on how mental health diagnoses are made, i.e., how they get recorded in RAPID. It may also be worth noting in the limitations section that these may an underestimate if they had mental health issues that had gone undetected/not diagnosed. Similarly how were de-identified records examined with Victoria Police) - was there a statistical linkage key used?

We have now added information about how diagnoses are recorded into RAPID in the method section. In regards to the de-identified records, yes, a linkage key was used. We have now also incorporated this information into the method section.

Please clarify why violent offending data time period was so variable - up to 18 months is reported in the method but the range indicated in the results sections suggests it was as early as 1-month for some - surely this would limit the chances of there being a reported offence?

This is a typographical error. The values reported actually refer to time to re-offence. We have now amended the text to reflect this. We have also included the appropriate information about follow up time with 6 months minimum for the entire sample up to 18 months.

The discussion could go further in unpacking the demonstrated relationship between psychiatric diagnosis and reoffending (e.g., poor impulse control, lack of insight etc).

We agree and have now included additional information about the relationship between psychiatric diagnoses and re-offending in the discussion section.

I also think the paper would benefit from my consistent methodology - (recidivism, re-offending, future violent criminal offending).

We assume this point relates to terminology. We agree and have made the terminology in relation to violent recidivism consistent throughout the manuscript

Reviewer 1 comments

\(1\) The likely lack of generalizability of the study findings is a significant concern, particularly in light of the stated goals of the study. The sample size is relatively small (N = 202), with an even smaller subset (n = 76) who reported lifetime CM use. Also, the sample was drawn from two youth justice facilities in one Australian state. The small, geographically limited sample raises concerns that the sample may not be representative. The manuscript appropriately acknowledged that "it was not possible to formally assess sample representativeness" (see Limitations), but it is difficult to overlook this limitation. A stated study goal was to assess lifetime prevalence use of CM, but to do so in a meaningful and defensible manner requires a larger, representative sample.

The determination of what constitutes a 'small sample' is dependent on what population we are hoping to generalise to. The average number of youths in detention in the whole of Australia varies from around 800 youths to 1000 depending on the time measured. Our sample included 202 participants (roughly 20% of the national amount). We do concede that the sample may not be representative, as the sample was drawn from a single Australian state and may differ demographically from populations in other states, we have tried to point this out to readers in the limitations section. We feel that the results are still meaningful for a number of reasons. Firstly, this is a novel area of research with no existing published studies on estimated lifetime CM use. Given this dearth of information, even a biased estimate is preferable to no estimate especially given that readers are provided with enough contextual information in both the method and limitations section to avoid overconfidence in the estimates provided. The alternative to the estimates we provide is to rely on pure guesswork. Secondly, estimates from smaller sample sizes are still meaningful provided that too much confidence is not placed on the results of statistical analyses. As has been pointed out numerous times, overall statistical estimates (say from meta-analytic methods) from any field are likely to be biased when small n studies are not published and available to base conclusions on.

\(2\) The manuscript indicates that informed consent was obtained from all participants over age 18, and that consent for participants under age 18 fell within the "mature minor" concept. However, there is no indication of whether anyone refused to provide informed consent, or whether any of the participants under age 18 were determined to lack the capacity to understand the nature of the study.

Thank you for identifying this omission. We have corrected the method to include a statement that indicates that all participants were determined to have capacity to understand the nature of the study and that no participants refused to provide informed consent.

\(3\) A related concern is the lack of information regarding the recruitment fraction. The manuscript states that the authors achieved a "high recruitment fraction" (see Limitations), but no other information is provided. As such, it is not possible to assess whether the sample size of 202 is a small, moderate, or large sample of the population of interest. Providing the census of the two facilities would be informative.

We agree that this is information that should have been included. We have amended the participant section to provide population level estimates from Government agencies to provide readers with the necessary information to gauge the sample size relative to population.

\(4\) The use of a binary variable for CM use (0 = no CM use; 1 = lifetime CM use) lacks sufficient specificity and sensitivity. When addressing this limitation, the manuscript stated: "Firstly, we examined only lifetime use of CM and did not include measurements of frequency of use, use within a specified period (e.g., past 12 months), or estimates of typical quantity used" (see Limitations). Acknowledging this limitation is laudable, but it is difficult to overlook. Given the binary nature of this variable, participants who used CM once are grouped with participants who used CM many times. Such a crude classification system does not acknowledge the differences that (likely) exist between those with limited CM use and those with extensive CM use; grouping them together adds too much noise to the data, and the study results pertaining to CM use, the relationship between CM use and other drug use, and the relationship between CM use and violence become less defensible and less meaningful. For example, concluding that more than one-third of the sample reported lifetime CM use could be misleading because we do not know what proportion of those participants used CM once versus many times. To be clear, using CM once is indeed lifetime CM use, but it may not make sense (given what we know about episodic versus chronic CM use) to group one-time CM users with chronic CM users.

We agree that this is an important limitation and largely agree with the reviewer that the relationship between CM use and outcomes would be more nuanced with further information on the extent of CM use among the sample. We have amended our discussion to more strongly point out this limitation. We do feel however, that the results represent a limited but important first step in an area where there has not been any published research and provide a broad estimate of the relationship between CM use, substance use and offending.

\(5\) There is a similar sensitivity problem related to the definition of violent offending. The manuscript defined violent recidivism as "any personal injury transgression that led to a police charge," which included "acts intended to cause or threaten to cause physical harm to a victim." There are two concerns. First, defining recidivism based on charges, as opposed to arrests or convictions, would benefit from being justified. Second, combining acts with threats introduces noise into the data because there are differences between acts of violence and threats of violence. Some justification for combining acts and threats would strengthen the manuscript.

We have provided further information to justify the definition of violent recidivism within the manuscript.

The use of charges as our measure of recidivism was chosen for a number of reasons. Firstly, the use of arrests as an outcome measure would underestimate the amount of violent recidivism given that not all charges for violence result in arrest. The use of charges was also preferred to convictions given the relatively small follow up period in the current study (6-18 months). The time needed for a case to proceed from incident to charge to trial to conviction would mean that the base rate for the outcome in the time period examined would be relatively low. Furthermore the use of conviction is likely to also underestimate offending given that mistrials and prosecution discretion are likely to artificially reduce the rate of violent recidivism in a way that is not necessarily accurate.

The grouping of threats alongside physical acts of violence is now commonplace. For example the World Health Organisation defines violence as "\"the intentional use of physical force or power, threatened or actual, against oneself, another person, or against a group or community\...\" (Krug et al., 2002). We have amended the method to make the reason for the grouping of the two forms of violence clearer.

\(6\) The manuscript does not include an a priori statistical power analysis. The manuscript mentions that the "modest sample size limited statistical power," but (a) it is not clear how the authors know that statistical power was in fact limited, and (b) the lack of a power analysis (and potentially low power) raises concerns about Type II errors.

The use of an a priori power analysis was not possible for the current analysis given that the data had already been collected prior to analysis. The reviewer is correct that we could not possibly 'know' that statistical power was limited, however we suspect that it is limited given that guidelines from simulation studies and textbooks suggest that we would require more data to estimate effects at sufficient power. For example, Peduzzi et al. (1996) offers the following formula for estimating sample size: N = (10\*K)/P, where K is the number of covariates and P is the proportion of outcome events in the sample. With our data (which is not necessarily representative of the population) we can use this rule of thumb to estimate in the case of model 2 that we would need 211 cases whereas we had in reality 198. We agree about the possibility of type II errors and we have now made this point in the discussion.

\(7\) The manuscript does not include any testable hypotheses

The lack of hypotheses was intentional. Given the novelty of research in this area, we did not feel comfortable specifying hypotheses.

\(8\) To support the assertion that the adolescent brain is still developing, the manuscript cites an article from 1999. The 1999 article is certainly a solid reference, but perhaps a more recent reference that reflects the current brain science would be more informative

We have now included a reference to more recent research in brain science which supports the assertion that the adolescent brain is still developing.

Reviewer 2 comments

1\. Section 2.1 needs more information about the sampling frame & sampling strategy- how were participants selected?

All young people (remanded and sentenced) in the two custodial centres were eligible to take part in the study so long as they were able to comprehend the purpose and nature of the study and then provide consent. Participants were eligible to participate if they were English speaking and able to comprehend the participatory explanation form. Detainees were not approached if Justice Centre staff deemed them to be of unstable mood or likely to exhibit extreme aggressive behavior if interviewed. The above information has now been incorporated into the paper.

2\. Regarding the associations between having a psychiatric diagnosis and violent recidivism, is it possible this could be explained by reverse causation- that is, violent offences led to psychiatric assessment which then resulted in a diagnosis being recorded?

This is not possible in the current study given that the psychiatric diagnoses were recorded prior to the recidivism.

3\. The comment "Our findings suggest that CM use on its own is unlikely to be an important consideration" etc over-reaches what this study shows, since it's possible the association with violence is confined to people who have used CM frequently (see Foulds et al\--Methamphetamine use and violence: findings from a longitudinal birth cohort"- Drug and Alcohol Dependence, in press). Thus an alternative conclusion would be that more detailed assessment of CM use- ie frequency, route of administration and presence of substance use disorder- is necessary to aid treatment selection. Though it is noted that no evidence-based treatments specific to methamphetamine use disorder exist at this time.

We wholeheartedly agree with this suggestion. We have amended the discussion to reflect this possibility.

4\. In Table 2, 3 and 4 the inclusion of rows for the reference categories (eg "no cannabis") is perhaps not necessary. Consider omitting the reference category rows unless these are essential to the data presentation.

We feel that the rows for the reference categories contain important descriptive information in terms of the numbers of individuals who did and did not have the outcome of interest (e.g. violence) in the reference category. This is potentially useful for those who may wish to incorporate the study in a future systematic review.
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